Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Cns Pharmaceuticals Inc (CNSP)

Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
CNS Pharmaceuticals (NASDAQ: CNSP) CEO Slated to Present at H.C. Wainwright Conference Investor Brand Network - Thu Sep 5, 9:05AM CDT

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be participating...

CNSP : 0.1482 (-0.54%)
CNS Pharmaceuticals (NASDAQ: CNSP) CEO Featured in Latest BioMedWire Podcast Episode Investor Brand Network - Wed Sep 4, 8:32AM CDT

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, is spotlighted...

CNSP : 0.1482 (-0.54%)
CNS Pharmaceuticals (NASDAQ: CNSP) CEO to Present at Virtual Biotech Investment Webinar Investor Brand Network - Wed Aug 28, 10:09AM CDT

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company...

CNSP : 0.1482 (-0.54%)
CNS Pharmaceuticals (NASDAQ: CNSP) CEO to be Featured in Virtual Investor CEO Connect Segment Investor Brand Network - Fri Aug 23, 8:31AM CDT

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be spotlighted...

CNSP : 0.1482 (-0.54%)
CNS Pharmaceuticals (NASDAQ: CNSP) Publishes Q2 2024 Results Investor Brand Network - Fri Aug 16, 10:23AM CDT

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today released...

CNSP : 0.1482 (-0.54%)
CNS Pharmaceuticals (NASDAQ: CNSP) Inks Exclusive License in ‘Transformational’ Step to Treating GBM Investor Brand Network - Tue Jul 30, 10:09AM CDT

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has entered...

CNSP : 0.1482 (-0.54%)
CNS Pharmaceuticals (NASDAQ: CNSP) to Present at SNO/ASCO CNS Cancer Conference Investor Brand Network - Fri Jul 26, 9:19AM CDT

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be participating...

CNSP : 0.1482 (-0.54%)
CNS Pharmaceuticals (NASDAQ: CNSP) Exec to Present at Virtual Investor Closing Bell Series Investor Brand Network - Wed Jul 17, 10:33AM CDT

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be featured...

CNSP : 0.1482 (-0.54%)
CNS Pharmaceuticals (NASDAQ: CNSP) Enters Securities Purchase Agreements Worth Estimated $1.98M Investor Brand Network - Mon Jul 8, 10:16AM CDT

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has entered...

CNSP : 0.1482 (-0.54%)
CNS Pharmaceuticals (NASDAQ: CNSP) Announces Pricing of Registered Direct, Concurrent Private Placement Investor Brand Network - Fri Jun 28, 10:40AM CDT

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company...

CNSP : 0.1482 (-0.54%)

Barchart Exclusives

3 Dividend Aristocrats that Could Double The Dividend Barchart - Fri Sep 13, 6:00PM CDT
Discover three Dividend Aristocrats poised for dividend growth and long-term returns. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot